Latest filing published 14 May 2007 for PANACOS PHARMACEUTICALS, INC., €6,595.
Insider track record
No signal scores available.
Closed purchases
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -87.1%Entry 4.07 · Close at T+365 0.52
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Surry Jeremy Hayward: trading record in brief
Filings by Surry Jeremy Hayward span 2 companies, the busiest being Panacos Pharmaceuticals, Inc. and Savient Pharmaceuticals Inc. The record holds 6 filings, for trades running from 30 December 2005 to 14 May 2007.
No open-market sale appears; the market trades are 4 purchases worth €32k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 2 share grants. 2007 to date brings 4 purchases and no sales.
Half of the purchases are above €7,862 and half below. Looking at 4 purchases old enough to measure, the stock rose over the following 90 days in 0% of cases; the median change was -33.9%. They describe history only and say nothing certain about the share price ahead.
Most recently, on 14 May 2007, the filings show an open-market purchase worth €6,595 in Panacos Pharmaceuticals, Inc. Publication is fast: at least half of the trades appear on SEC (Form 4) on the same day. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Surry Jeremy Hayward
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,100 shares@ US$4.27Common StockSEC:0001181431-07-032101:0Canonical exit: 12 Aug 2007 (T+90)
- 2,900 shares@ US$4.28Common StockSEC:0001181431-07-032101:1Canonical exit: 12 Aug 2007 (T+90)
- 1,600 shares@ US$4.29Common StockSEC:0001181431-07-032101:2Canonical exit: 12 Aug 2007 (T+90)
- 3,400 shares@ US$4.30Common StockSEC:0001181431-07-032101:3Canonical exit: 12 Aug 2007 (T+90)
- 1,500 shares@ US$5.33Common Stock, $.01 par value per shareSEC:0001230295-06-000086:0
- 2,139 shares@ US$3.74Common Stock, $.01 par value per shareSEC:0001230295-06-000002:0
6 of 6 declarations
